PARP inhibitors as maintenance treatment for pancreatic cancer patients with germline BRCA mutations

被引：0
|
作者：
Kawecki, Maciej [1 ]
机构：
[1] Maria Sklodowska Curie Inst Oncol, Dept Radiotherapy & Oncol, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2019年 / 15卷 / 03期
关键词：
D O I：
10.5603/OCP.2019.0023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：190 / 193
页数：4
相关论文
共 50 条
  • [21] Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations
    Jorge, Soledad
    Swisher, Elizabeth M.
    Norquist, Barbara M.
    Pennington, Kathryn P.
    Gray, Heidi J.
    Urban, Renata R.
    Garcia, Rochelle L.
    Doll, Kemi M.
    GYNECOLOGIC ONCOLOGY REPORTS, 2019, 29 : 113 - 117
  • [22] Venous thromboembolism incidence in cancer patients with germline BRCA mutations
    Munoz, A. J.
    de Toro, M.
    Ortega, L.
    Lopez, C.
    Gutierrez, A.
    Juliao, D. S.
    Arregui, M.
    Lobato, N.
    Echavarria, I
    Marquez-Rodas, I
    Martin, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (01): : 154 - 158
  • [23] POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
    Golan, T.
    Hammel, P.
    Reni, M.
    Van Cutsem, E.
    Mercade, T. Macarulla
    Hall, M. J.
    Park, J. O.
    Hochhauser, D.
    Arnold, D.
    Oh, D-Y.
    Reinacher-Schick, A.
    Tortora, G.
    Algul, H.
    O'Reilly, E. M.
    Bordia, S.
    McGuinness, D.
    Cui, K. Y.
    Locker, G.
    Kindler, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1086 - S1087
  • [24] POLO: subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
    Arnold, D.
    Golan, T.
    Hammel, P.
    Reni, M.
    Van Cutsem, E.
    Macarulla, T.
    Hall, M. J.
    Park, J. O.
    Hochhauser, D.
    Oh, D. -Y
    Reinacher-Schick, A.
    Tortora, G.
    Alguel, H.
    O'Reilly, E. M.
    Bordia, S.
    McGuinness, D.
    Cui, K. Y.
    Kindler, H. L.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 221 - 221
  • [25] Analysis of BRCA Germline Mutations in Chinese Prostate Cancer Patients
    Chen, Wei
    Xia, Wei
    Xue, Song
    Huang, Hang
    Lin, Qi
    Liu, Yi
    Liu, Tongtong
    Zhang, Yiqun
    Zhang, Panwang
    Wang, Jianfei
    Yang, Yining
    Dong, Baijun
    Yu, Zhixian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Venous thromboembolism incidence in cancer patients with germline BRCA mutations
    A. J. Muñoz
    M. de Toro
    L. Ortega
    C. López
    A. Gutiérrez
    D. S. Juliao
    M. Arregui
    N. Lobato
    I. Echavarría
    I. Márquez-Rodas
    M. Martín
    Clinical and Translational Oncology, 2022, 24 : 154 - 158
  • [27] Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations
    Lambertini, Matteo
    Ameye, Lieveke
    Hamy, Anne-Sophie
    Zingarello, Anna
    Poorvu, Philip D.
    Carrasco, Estela
    Grinshpun, Albert
    Han, Sileny
    Rousset-Jablonski, Christine
    Ferrari, Alberta
    Paluch-Shimon, Shani
    Cortesi, Laura
    Senechal, Claire
    Miolo, Gianmaria
    Pogoda, Katarzyna
    Perez-Fidalgo, Jose Alejandro
    De Marchis, Laura
    Ponzone, Riccardo
    Livraghi, Luca
    Estevez-Diz, Maria Del Pilar
    Villarreal-Garza, Cynthia
    Dieci, Maria Vittoria
    Clatot, Florian
    Berliere, Martine
    Graffeo, Rossella
    Teixeira, Luis
    Cordoba, Octavi
    Sonnenblick, Amir
    Pais, Helena Luna
    Ignatiadis, Michail
    Paesmans, Marianne
    Partridge, Ann H.
    Caron, Olivier
    Saule, Claire
    Del Mastro, Lucia
    Peccatori, Fedro A.
    Azim, Hatem A., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 3012 - 3023
  • [28] Analysis of BRCA germline mutations in Chinese prostate cancer patients
    Chen, W.
    Xia, W.
    Xue, S.
    Huang, H.
    Lin, Q.
    Liu, T.
    Yang, Y.
    Wang, J.
    Zhang, Y.
    Dong, B.
    Yu, Z.
    EUROPEAN UROLOGY, 2021, 79 : S603 - S603
  • [29] Prevalence of germline BRCA and mismatch repair (MMR) gene mutations in pancreatic cancer
    Selander, Iris
    Grant, Robert
    Connor, Ashton
    Selvarajah, Shamini
    Borgida, Ayelet
    Briollais, Laurent
    Lerner-Ellis, Jordan
    Holter, Spring
    Gallinger, Steven
    CANCER RESEARCH, 2015, 75
  • [30] PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer
    Devashish Desai
    Pushti Khandwala
    Meghana Parsi
    Rashmika Potdar
    Medical Oncology, 2021, 38
12345